Abstract TH166: Trends in Hypertension-Dementia Related Co-Mortality in the United States, 1999-2024
Hypertension · 2026-10 · 83 (Suppl_1)
DOI: 10.1161/hyp.83.suppl_1.th166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hypertension, 2026-10. Verfasst von Jocelyn Wensel und 4 weiteren Autor:innen.
Themen: Demenz
Abstract (Originalsprache)
Introduction
Hypertension (HTN) and dementia (Alzheimer's disease (AD)/Vascular Dementia (VaD)) have a bi-directional relationship rooted in structural change, metabolites and stress markers of cell damage, and aging related changes. Hypertension markers such as high sensitivity cardiac troponin, natriuretic peptides, C-reactive protein as well as elevated dimethylarginines (ADMA) reflect endothelial dysfunction and hypertensive pathophysiology. Additionally, markers of cognitive disease, such as amyloid-beta, Tau protein, and alpha-synuclein decrease arterial wall compliance and disrupt cardiac nervous conduction.
Methods
The CDC WONDER Multiple Cause-of-Death dataset (1999-2024) was used to analyze mortality trends in adults aged ≥ 25 years using ICD-10 codes for HTN (I10) and dementia/vascular cognitive impairment (F01.1, F01.2, F01.3, F01.8, F01.9, F03, G30.9). Results were stratified by age, sex, race, urbanization and census region. Age-adjusted mortality rates (AAMR) were quantified per 100,000 persons with 95% confidence intervals (95%CI). Annual percent change (APC) and average annual percent change (AAPC) were calculated using Joinpoint regression software.
Results
A total of 1,397,623 HTN and AD/VaD-related deaths occurred between 1999 and 2024. Overall, AAMR increased sharply from 1999-2001, then more gradually through 2024 (AAPC:7.7; 95%CI:6.4-9.2). Women had a higher AAMR (AAPC:7.6; 95%CI:6.3-9.1). African Americans (AAPC:6.8; 95%CI:5.8-8.7) had the highest AAMR; AI/AN and NH/PI (AAPC:8.1; 95%CI:6.3-10.5) the lowest. Adults 45-64 had low steady AAMR, while those >65 mirrored the overall trend (AAPC:7.7; 95%CI:6.4-9.2). Metro AAMR rose less from 2001-2024 (AAPC:8.6; 95%CI:6.9-10.6). Midwest (AAPC:7.2; 95%CI:5.9-8.8) and West (AAPC:6.9; 95%CI:5.6-8.3) rose more slowly, mirroring metro.
Conclusions
HTN-AD co-mortality increased significantly from 1999-2024 with marked disparities between sex, race, age, region and urbanization. The difference in HTN-AD/VaD co-mortality seen with higher AAMR in women, African Americans, adults ≥65 years, non-metro regions, and residents of the Northeast and South census may reflect multiple confounding factors and the effects of social infrastructure on chronic disease management, identifying risk factors, pre-clinical lab value screenings and access to care. The results support a targeted approach to HTN-AD, early detection of risk factors and preventive care measures in these high burden subgroups.
Zitieren
APA
Wensel, J., Chaudhary, I., Duseja, N., ALI, S. J., & Nadeem, L. (2026). Abstract TH166: Trends in Hypertension-Dementia Related Co-Mortality in the United States, 1999-2024. Hypertension, 83(Suppl_1). https://doi.org/10.1161/hyp.83.suppl_1.th166
Vancouver
Wensel J, Chaudhary I, Duseja N, ALI SJ, Nadeem L. Abstract TH166: Trends in Hypertension-Dementia Related Co-Mortality in the United States, 1999-2024. Hypertension. 2026;83(Suppl_1). doi:10.1161/hyp.83.suppl_1.th166
BibTeX
@article{Wensel2026,
author = {Wensel, Jocelyn and Chaudhary, Ishika and Duseja, Nikhil and ALI, Syed Jawad and Nadeem, Laiba},
title = {Abstract TH166: Trends in Hypertension-Dementia Related Co-Mortality in the United States, 1999-2024},
journal = {Hypertension},
year = {2026},
volume = {83},
number = {Suppl_1},
doi = {10.1161/hyp.83.suppl_1.th166}
}
EUVIMED